课题基金 / 基金详情

项目摘要

项目成果

HARTMUT W. JAESCHKE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Liver diseases including alcohol- and drug-induced liver injury, fatty liver disease, viral hepatitis, and liver cancer affects millions of people in he US. For the past 9 years the COBRE supported the recruitment of 15 junior faculty engaged in liver research and assisted in the development of highly successful core laboratories at the University of Kansas Medical Center. These COBRE-supported faculty and core users published more than 500 publications and generated more than $38 million of grant funding including 24 R01 grants. In addition, this led to the establishment of a Liver Center at KUMC and a liver tissue bank. Overall, the COBRE Phase I and II were instrumental in establishing a flourishing liver research community and creating an important infrastructure to support liver research and other areas of biomedical research at KUMC and beyond. This application requests five years of funding for the Phase III of this COBRE, during which we will pursue the following specific aims: 1. To provide administrative support for the successful operation of the COBRE; 2.To improve and sustain two scientific cores, the human Liver Cell Isolation Core and the Analytical Core, so that they can enhance the research capabilities of faculty at KUMC and at KU; 3. To operate a pilot grants program to provide incentives for pursuing new liver research opportunities and collaboration. The result will be a very strong and highly motivated group of senior and mid-career liver research scientists at KUMC who form the basis for NIH-funded Liver Center and/or program project grant applications. In addition, KUMC assists several vital, self-sustaining core laboratories that support liver and other biomedical research. Thus, the overall impact of this COBRE at KUMC will substantial and long-lasting.
期刊论文(159)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bbrc.2018.08.013
发表时间: 2018-09-18
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Adams A, Weinman SA, Wozniak AL]
通讯作者: Wozniak AL
DOI: 10.1016/j.cotox.2017.10.011
发表时间: 2018-03
期刊: Current opinion in toxicology
影响因子: 4.6
作者: [Ramachandran A, Jaeschke H]
通讯作者: Jaeschke H
DOI: 10.1177/1091581817706067
发表时间: 2017
期刊: International journal of toxicology
影响因子: 2.2
作者: [McGreal SR, Rumi K, Soares MJ, Woolbright BL, Jaeschke H, Apte U]
通讯作者: Apte U
DOI: 10.1016/j.apsb.2021.11.010
发表时间: 2021-12
期刊: Acta pharmaceutica Sinica. B
影响因子: --
作者: [Qian H, Bai Q, Yang X, Akakpo JY, Ji L, Yang L, Rülicke T, Zatloukal K, Jaeschke H, Ni HM, Ding WX]
通讯作者: Ding WX
92
    Core B: Liver Cell Isolation Core
    Mechanisms of Liver Injury and Diseases
    Core A: Administrative Core
    Mechanisms of Liver Injury and Diseases
    海外基金